Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Sandini

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 28, 2022
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatmentRaffaele De Luca, Luca Gianotti, Paolo Pedrazzoli, et al.
Annals of Surgery|October 11, 2018
Preoperative Biliary Stenting and Major Morbidity After Pancreatoduodenectomy: Does Elapsed Time Matter?: The FRAGERITA Study GroupMarta Sandini, Kim C Honselmann, David J Birnbaum, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 29, 2020
Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort studyLouisa Bolm, Kristina Ohrner, Gennaro Nappo, et al.
Annals of Surgery|July 18, 2020
Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic CancerKim C Honselmann, Ilaria Pergolini, Carlos Fernandez-Del Castillo, et al.
JAMA Surgery|May 19, 2021
Risk of the Watch-and-Wait Concept in Surgical Treatment of Intraductal Papillary Mucinous NeoplasmChristine Tjaden, Marta Sandini, André L Mihaljevic, et al.
Cancer Research Communications|July 29, 2025
Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5Thomas Hank, Annie Li, Louisa Bolm, et al.
Annals of Surgical Oncology|March 23, 2024
Predicting the Risk of Morbidity by GLIM-Based Nutritional Assessment and Body Composition Analysis in Oncologic Abdominal Surgery in the Context of Enhanced Recovery Programs : The PHase Angle Value in Abdominal Surgery (PHAVAS) StudyMarta Sandini, Luca Gianotti, Salvatore Paiella, et al.
Annals of Surgical Oncology|May 11, 2020
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic AdenocarcinomaIlaria Trestini, Salvatore Paiella, Marta Sandini, et al.
Surgery|May 27, 2022
Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international studyJulie Perinel, Gennaro Nappo, Alessandro Zerbi, et al.
World Journal of Surgery|June 27, 2019
Association Between Compliance to an Enhanced Recovery Protocol and Outcome After Elective Surgery for Gastric Cancer. Results from a Western Population-Based Prospective Multicenter StudyLuca Gianotti, Uberto Fumagalli Romario, Stefano De Pascale, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 28, 2022
Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatmentRaffaele De Luca, Luca Gianotti, Paolo Pedrazzoli, et al.
Annals of Surgery|October 11, 2018
Preoperative Biliary Stenting and Major Morbidity After Pancreatoduodenectomy: Does Elapsed Time Matter?: The FRAGERITA Study GroupMarta Sandini, Kim C Honselmann, David J Birnbaum, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 29, 2020
Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort studyLouisa Bolm, Kristina Ohrner, Gennaro Nappo, et al.
Annals of Surgery|July 18, 2020
Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic CancerKim C Honselmann, Ilaria Pergolini, Carlos Fernandez-Del Castillo, et al.
JAMA Surgery|May 19, 2021
Risk of the Watch-and-Wait Concept in Surgical Treatment of Intraductal Papillary Mucinous NeoplasmChristine Tjaden, Marta Sandini, André L Mihaljevic, et al.
Cancer Research Communications|July 29, 2025
Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5Thomas Hank, Annie Li, Louisa Bolm, et al.
Annals of Surgical Oncology|March 23, 2024
Predicting the Risk of Morbidity by GLIM-Based Nutritional Assessment and Body Composition Analysis in Oncologic Abdominal Surgery in the Context of Enhanced Recovery Programs : The PHase Angle Value in Abdominal Surgery (PHAVAS) StudyMarta Sandini, Luca Gianotti, Salvatore Paiella, et al.
Annals of Surgical Oncology|May 11, 2020
Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic AdenocarcinomaIlaria Trestini, Salvatore Paiella, Marta Sandini, et al.
Surgery|May 27, 2022
Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international studyJulie Perinel, Gennaro Nappo, Alessandro Zerbi, et al.
World Journal of Surgery|June 27, 2019
Association Between Compliance to an Enhanced Recovery Protocol and Outcome After Elective Surgery for Gastric Cancer. Results from a Western Population-Based Prospective Multicenter StudyLuca Gianotti, Uberto Fumagalli Romario, Stefano De Pascale, et al.
Pageof 7